New Study to Get More Minorities Involved in Genetic Testing
837 articles
Terms of Use
Copyright The entire content included in this Website, letswinpc.org, including but not limited to text, graphics, or code, is copyrighted as a collective work under the United States’ and other copyright laws, and is the property of Let’s Win. The collective work includes works that are licensed to Let’s Win. ALL RIGHTS RESERVED. You may […]
Jane Randel, Chair
Jane Randel is a Social Impact consultant and co-founder of Karp Randel, a consultancy designed to help corporations, foundations and individuals achieve their business and personal goals while making a positive impact on society. She is also a co-founder of NO MORE, a national initiative intended to tackle domestic violence and sexual assault while generating […]
Gil Bashe
Our health system is hard to navigate — sometimes the sectors seem at odds. But, patients expect that each piece of the medical puzzle – physician, provider, payer, pharma and policy – will focus on their wellbeing. Through my 30+ years in health, I’ve believed that communication with the patient is a crucial part of […]
Let’s Win Launches Online Video Series Featuring Long-Term Pancreatic Cancer Survivors
Meet long-term survivors of pancreatic cancers, in our new Survivors Video Series. The introductory video was launched in January at a cancer symposium.
Calming the Storm of a Pancreatic Cancer Diagnosis
Social worker Angie Heller and caregiver Richard Cohen describe ways patients and loved ones can focus on what matters most after diagnosis.
Investigating a Drug Used for Other Cancers
In a clinical trial, researchers are adding the drug decitabine to gemcitabine, for patients with advanced cancer that is not responding to treatment.
Electrical Current to Help Relieve Jaundice
A clinical trial uses electrical current, in the form of radiofrequency ablation, to test the best technique for keeping a stent open to relieve jaundice.
Immunotherapy for Pancreatic Neuroendocrine Tumors
A clinical trial combines the immunotherapy drug pembrolizumab with lanreotide, a drug typically used to treat pancreatic neuroendocrine tumors.